Stochastic analysis of pre-and postexposure prophylaxis against hiv infection

SIAM Journal on Applied Mathematics

Volumn 73, Issue 2, 2013, Pages 904-928

  Conway, Jessica M ^a   Konrad, Bernhard P ^b   Coombs, Daniel ^b  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Branching process; HIV; HIV prevention; Postexposure prophylaxis; Preexposure prophylaxis; Viral dynamics

Indexed keywords

BRANCHING PROCESS; HIV; HIV PREVENTION; POST-EXPOSURE; PRE-EXPOSURE;

COMPUTER SIMULATION; ENZYME INHIBITION; PROBABILITY DISTRIBUTIONS; RISK PERCEPTION;

DYNAMICS;

EID: 84878084179     PISSN: 00361399     EISSN: None     Source Type: Journal    
DOI: 10.1137/120876800     Document Type: Article

References (53)

1. P. L. Anderson, J. J. Kiser, E. M. Gardner, J. E. Rower, A. Meditz, and R. M. Grant, Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection, J. Antimicrob Chemother, 66 (2011), pp. 240-250.
2. J. M. Baeten, D. Donnell, P. Ndase, N. R. Mugo, J. D. Campbell, J. Wangisi, J. W. Tappero, E. A. Bukusi, C. R. Cohen, E. Katabira, A. Ronald, E. Tumwesigye, E. Were, K. H. Fife, J. Kiarie, C. Farquhar, G. John-Stewart, A. Kakia, J. Odoyo, A. Mucunguzi, E. Nakku-Joloba, R. Twesigye, K. Ngure, C. Apaka, H. Tamooh, F. Gabona, A. Mujugira, D. Panteleeff, K. K. Thomas, L. Kidoguchi, M. Krows, J. Revall, S. Morrison, H. Haugen, M. Emmanuel-Ogier, L. Ondrejcek, R. W. Coombs, L. Frenkel, C. Hendrix, N. N. Bumpus, D. Bangsberg, J. E. Haberer, W. S. Stevens, J. R. Lingappa, C. Celum, and Partners PrEP Study Team, Antiretroviral prophylaxis for HIV prevention in heterosexual men and women, N. Engl. J. Med., 367 (2012), pp. 399-410.
3. J. A. Bartlett, R. DeMasi, J. Quinn, C. Moxham, and F. Rousseau, Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults, AIDS, 15 (2001), pp. 1369-1377.
4. M. R. Betts, D. R. Ambrozak, D. C. Douek, S. Bonhoeffer, J. M. Brenchley, J. P. Casazza, R. A. Koup, and L. J. Picker, Analysis of total human immunodeficiency virus (HIV)-specific CD4 and CD T-cell responses: Relationship to viral load in untreated HIV infection, J. Virol., 75 (2001), pp. 11983-11991.
5. J. Bryant, L. Baxter, and S. Hird, Non-occupational postexposure prophylaxis for HIV: A systematic review, Health Technol. Assess., 13 (2009), pp. iii, ix-x, 1-60.
6. D. M. Cardo, D. H. Culver, C. A. Ciesielski, P. U. Srivastava, R. Marcus, D. Abiteboul, J. Heptonstall, G. Ippolito, F. Lot, P. McKibben, and D. M. Bell, A case-control study of HIV seroconversion in health care workers after percutaneous exposure, New Engl. J. Med., 337 (1997), pp. 1485-1490.
7. H. Y. Chen, M. D. Mascio, A. S. Perelson, D. D. Ho, and L. Zhang, Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques, Proc. Natl. Acad. Sci. USA, 104 (2007), pp. 19079-19084.
8. M. S. Cohen and L. R. Baden, Preexposure prophylaxis for HIV-where do we go from here?, N. Engl. J. Med., 367 (2012), pp. 459-461.
9. J. M. Conway and D. Coombs, A stochastic model for latently infected cell reactivation and viral blip generation in treated HIV patients, PLoS Comput. Biol., 7 (2011), e1002033.
10. N. M. Dixit, M. Markowitz, D. D. Ho, and A. S. Perelson, Estimates of intracellular delay and average drug efficacy from viral load data of HIV-infected individuals under antiretroviral therapy, Antiviral Therapy, 9 (2004), pp. 237-246.
11. C. W. Gardiner, Handbook of Stochastic Methods, Springer-Verlag, Berlin, 2004.
12. D. T. Gillespie, Exact stochastic simulation of coupled chemical reactions, J. Phys. Chem., 81 (1977), pp. 2340-2361.
13. R. M. Grant, J. R. Lama, P. L. Anderson, V. McMahan, A. Y. Liu, L. Vargas, P. Goic-ochea, M. Casapía, J. V. Guanira-Carranza, M. E. Ramirez-Cardich, O. Montoya-Herrera, T. Fernández, V. G. Veloso, S. P. Buchbinder, S. Chariyalertsak, M. Schechter, L.-G. Bekker, K. H. Mayer, E. G. Kallás, K. R. Amico, K. Mulligan, L. R. Bushman, R. J. Hance, C. Ganoza, P. Defechereux, B. Postle, F. Wang, J. J. McConnell, J.-H. Zheng, J. Lee, J. F. Rooney, H. S. Jaffe, A. I. Martinez, D. N. Burns, D. V. Glidden, and the iPrEx Study Team, Preexposure chemoprophy-laxis for HIV prevention in men who have sex with men, N. Engl. J. Med., 363 (2010), pp. 2587-2599.
14. R. H. Gray, M. J. Wawer, R. Brookmeyer, N. K. Sewankambo, D. Serwadda, F. Wabwire-Mangen, T. Lutalo, X. B. Li, T. vanCott, and T. C. Quinn, Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda, Lancet, 357 (2001), pp. 1149-1153.
15. A. T. Haase, Population biology of HIV-1 infection: Viral and CD4+T cell demographics and dynamics in lymphatic tissues, Annu. Rev. Immunol., 17 (1999), pp. 625-656.
16. A. T. Haase, Targeting early infection to prevent HIV-1 mucosal transmission, Nature, 464 (2010), pp. 217-223.
17. A. T. Haase, Early events in sexual transmission of HIV and SIV and opportunities for interventions, Annu. Rev. Immunol. Rev. Med., 62 (2011), pp. 127-139.
18. A. T. Haase, K. Henry, M. Zupancic, G. Sedgewick, R. A. Faust, H. Melroe, W. Cavert, K. Gebhard, K. Staskus, Z.-Q. Zhang, P. J. Dailey, H. H. Balfour Jr., A. Erice, and A. S. Perelson, Quantitative image analysis of HIV-1 infection in lymphoid tissue, Science, (1996), pp. 985-989.
19. J. M. Heffernan and L. M. Wahl, Monte Carlo estimates of natural variation in HIV infection, J. Theoret. Biol., 236 (2005), pp. 137-153.
20. B. L. Jilek, M. Zarr, M. E. Sampah, S. A. Rabi, C. K. Bullen, J. Lai, L. Shen, and R. F. F Siliciano, A quantitative basis for antiretroviral therapy for HIV-1 infection, Nat. Med., 18 (2012), pp. 446-451.
21. S. Karlin and H. M. Taylor, A First Course in Stochastic Processes, 2nd ed., Academic Press, New York, 1975.
22. B. F. Keele, E. E. Giorgi, J. F. Salazar-Gonzalez, J. M. Decker, K. T. Pham, M. G. Salazar, C. X. Sun, T. Grayson, S. Y. Wang, H. Li, X. P. Wei, C. L. Jiang, J. L. Kirchherr, F. Gao, J. A. Anderson, L. H. Ping, R. Swanstrom, G. D. Tomaras, W. A. Blattner, P. A. Goepfert, J. M. Kilby, M. S. Saag, E. L. Delwart, M. P. Busch, M. S. Cohen, D. C. Montefiori, B. F. Haynes, B. Gaschen, G. S. Athreya, H. Y. Lee, N. Wood, C. Seoighe, A. S. Perelson, T. Bhattacharya, B. T. Korber, B. H. Hahn, and G. M. Shaw, Identification and characterisation of transmitted and early founder virus envelopes in primary HIV-1 infection, Proc. Natl. Acad. Sci. USA, 105 (2008), pp. 7552-7557.
23. H. J. Kim and A. S. Perelson, Viral and latent reservoir persistence in HIV-1-infected patients on therapy, PLoS Comput. Biol., 2 (2006), pp. 1232-1247.
24. S. H. Kleinman, N. Lelie, and M. P. Busch, Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion, Transfusion, 49 (2009), pp. 2454-2489.
25. O. Krakovska and L.M. Wahl, Optimal drug treatment regimens for HIV depend on adherence, J. Theoret. Biol., 246 (2007), pp. 499-509.
26. R. J. Landovitz and J. S. Currier, Postexposure prophylaxis for HIV infection, New Engl. J. Med., 361 (2009), pp. 1768-1775.
27. M. B. Lappin, J. M. Weiss, V. Delattre, B. Mai, H. Dittmar, C. Maier, K. Manke, S. Grabbe, S. Martin, and J. C. Simon, Analysis of mouse dendritic cell migration in vivo upon subcutaneous and intravenous injection, Immunology, 98 (1999), pp. 181-188.
28. E. Le Corfec and H. C. Tuckwell, Variability in early HIV-1 population dynamics, AIDS, 12 (1998), pp. 960-962.
29. M. Markowitz, M. Louie, A. Hurley, E. Sun, and M. Di Mascio, A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo, J. Virol., 77 (2003), pp. 5037-5038.
30. A. J. Marozsan, E. Fraundorf, A. Abraha, H. Baird, D. Moore, R. Troyer, I. Nankja, and E. J. Arts, Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates, J. Virol., 78 (2004), pp. 11130-11141.
31. S. J. Merrill, The stochastic dance of early HIV infection, J. Comput. Appl. Math., 184 (2005), pp. 242-257.
32. C. J. Miller, N. J. Alexander, S. Sutjipto, A. A. Lackner, A. Gettie, A. G. Hendrickx, L. J. Lowenstine, M. Jennings, and P. A. Marx, Genital mucosal transmission of simian immunodeficiency virus-animal-model for heterosexual transmission of human immunodeficiency virus, J. Virol., 63 (1989), pp. 4277-4284.
33. C. J. Miller, Q. S. Li, K. Abel, E. Y. Kim, Z. M. Ma, S. Wietgrefe, L. La Franco-Scheuch, L. Compton, L. J. Duan, M. D. Shore, M. Zupancic, M. Busch, J. Carlis, S. Wolinksy, and A. T. Haase, Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus, J. Virol., 79 (2005), pp. 9217-9227
34. J. E. Pearson, P. Krapivsky, and A. S. Perelson, Stochastic theory of early viral infection: Continuous versus burst production of virions, PLoS Comput. Biol., 7 (2011), e1001058.
35. A. S. Perelson, D. E. Kirschner, and R. J. De Boer, Dynamics of HIV infection of CD4+ T cells, Math. Biosci., 114 (1993), p. 81-125.
36. L. Peterson, D. Taylor, R. Roddy, G. Belai, P. Phillips, K. Nanda, R. Grant, E. E. Kekawo Clarke, A. S. Doh, R. Ridzon, H. S. Jaffe, and W. Cates, Tenofovir Diso-proxil Fumarate for prevention of HIV infection in women: A phase 2, double-blind, randomized, placebo-controlled trial, PLoS Clin. Trials, 2 (2007), p. e72.
37. B. Ramratnam, S. Bonhoeffer, J. Binley, A. Hurley, and L. Q. Zhang, Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis, Lancet Infect. Dis., 354 (1999), pp. 1782-1785.
38. R. M. Ribeiro, L. Q. Qin, L. L. Chavez, D. Li, S. G. Self, and A. S. Perelson, Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection, J. Virol., 84 (2010), pp. 6096-6102.
39. M. E. Roland, T. B. Neilands, M. R. Krone, M. H. Katzl, K. Franses, R. M. Grant, M. P. Busch, F. M. Hecht, B. L. Shacklett, J. O. Kahn, J. D. Bamberger, T. J. Coates, M. A. Chesney, and J. N. Martin, Seroconversion following nonoccupational postexposure prophylaxis against HIV, Clin. Infect. Dis., 41 (2005), pp. 1507-1513.
40. P. Rusert, M. Fischer, B. Joos, C. Leemann, H. Kuster, M. Flepp, S. Bonhoeffer, H. F. Gunthard, and A. Trkola, Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol, Virology, 326 (2004), pp. 113-129.
41. G. A. Snyder, J. Ford, P. Torabi-Parizi, J. A. Arthos, P. Schuck, M. Colonna, and P. D. Sun, Characterization of DC-SIGN/R interaction with human immunodeficiency virus type 1 gp120 and ICAM molecules favors the receptor's role as an antigen-capturing rather than an adhesion receptor, J. Virol., 79 (2005), pp. 4589-4598.
42. L. Sompayrac, How the Immune System Works, Wiley-Blackwell, Oxford, UK, 2008.
43. M. C. Thigpen, P. M. Kebaabetswe, L. A. Paxton, D. K. Smith, C. E. Rose, T. M. Segolodi, F. L. Henderson, S. R. Pathak, F. A. Soud, K. L. Chillag, R. Mutanhaurwa, L. I. Chirwa, M. Kasonde, D. Abebe, E. Buliva, R. J. Gvetadze, S. Johnson, T. Sukalac, V. T. Thomas, C. Hart, J. A. Johnson, C. K. Malotte, C. W. Hendrix, J. T. Brooks, and TDF2 Study Group, Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana, N. Engl. J. Med., 367 (2012), pp. 423-434.
44. C. C. Tsai, P. Emau, K. E. Follis, T. W. Beck, R. E. Benveniste, N. Bischof-berger, J. D. Lifson, and W. R. Morton, Effectiveness of postinoculation (R)-9-(2-Phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment, J. Virol., 72 (1998), pp. 4265-4273.
45. C. C. Tsai, K. E. Follis, A. Sabo, T. W. Beck, R. F. Grant, N. Bischofberger, R. E. Benveniste, and R. Black, Prevention of SIV infection in macaques by (R)-9-(2-Phosphonylmethoxypropyl)Adenine, Science, 270 (1995), pp. 1197-1199.
46. H. C. Tuckwell and E. Le Corfec, A stochastic model for early HIV-1 population dynamics, J. Theoret. Biol., 195 (1998), pp. 451-463.
47. N. K. Vaidya, R. M. Ribeiro, C. J. Miller, and A. S. Perelson, Viral dynamics during primary simian immunodeficiency virus infection: Effect of time-dependent virus infectivity, J. Virol., 84 (2010), pp. 4302-4310.
48. L. Van Damme, A. Corneli, K. Ahmed, K. Agot, J. Lombaard, S. Kapiga, M. Malahleha, F. Owino, R. Manongi, J. Onyango, L. Temu, M. C. Monedi, P. Mak'Oketch, M. Makanda, I. Reblin, S. E. Makatu, L. Saylor, H. Kiernan, S. Kirkendale, C. Wong, R. Grant, A. Kashuba, K. Nanda, J. Mandala, K. Fransen, J. Deese, T. Crucitti, T. D. Mastro, D. Taylor, and FEM-PrEP Study Group, Preexposure prophylaxis for HIV infection among African women, N. Engl. J. Med., 367 (2012), pp. 411-422.
49. M. J. Wawer, R. H. Gray, N. K. Sewankambo, D. Serwadda, X. B. Li, O. Laeyendecker, N. Kiwanuka, G. Kigozi, M. Kiddugavu, T. Lutalo, F. Nalugoda, F. Wabwire-Mangen, M. P. Meehan, and T. C. Quinn, Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda, J. Infect. Dis., 191 (2005), pp. 1403-1409
50. WHO HIV/AIDS Programme, Post-Exposure Prophylaxis to Prevent HIV Infection: Joint WHO/ILO Guidelines on Post-Exposure Prophylaxis (PEP) to Prevent HIV Infection, World Health Organization, Geneva, Switzerland, 2007.
51. L. Wu and V. N. KewalRamani, Dendritic-cell interactions with HIV: Infection and viral dissemination, Nat. Rev. Immunol., 6 (2006), pp. 859-868.
52. A. J. Yates, M. Van Baalen, and R. Antia, Virus replication strategies and the critical CTL numbers required for the control of infection, PLoS Comput. Biol., 7 (2011), e1002274.
53. L. Zhang, R. M. Ribeiro, J. R. Mascola, M. G. Lewis, G. Stiegler, H. Katinger, A. S. Perelson, and M. P. Davenport, Effects of antibody on viral kinetics in simian/human immunodeficiency virus infection: Implications for vaccination, J. Virol., 78 (2004), pp. 5520-5522.